Supernus Pharmaceuticals, Inc. (SUPN)
53.92
-0.35
(-0.64%)
USD |
NASDAQ |
Mar 06, 16:00
53.92
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Free Cash Flow : 45.99M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 1.969B |
| BridgeBio Pharma, Inc. | -455.50M |
| Corcept Therapeutics, Inc. | 141.78M |
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Cytokinetics, Inc. | -534.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 19.86M |
| Cash from Investing (Quarterly) | -51.31M |
| Cash from Financing (Quarterly) | 8.526M |
| Free Cash Flow Per Share (Quarterly) | 0.3389 |
| Free Cash Flow to Equity (Quarterly) | 20.67M |
| Free Cash Flow to Firm (Quarterly) | 19.43M |
| Free Cash Flow Yield | 1.51% |